SCHEMBL28405132

SCHEMBL28405132

OC1(c2ccc3c(Cl)ncnn23)O[C@H](COCc2ccccc2)[C@@H](OCc2ccccc2)[C@H]1OCc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 2/20 0.38
▸ PTPN1 P18031 9/20 0.35
▸ CDC25B P30305 8/20 0.35
▸ PDE2A O00408 2/20 0.35
▸ HTR1A P08908 1/20 0.35
▸ PTPN2 P17706 5/20 0.34
▸ PTPN11 Q06124 5/20 0.34
▸ PTPN6 P29350 4/20 0.34
▸ GJB2 P29033 1/20 0.32
▸ NT5E P21589 1/20 0.32
▸ ACHE P22303 1/20 0.31
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31
▸ CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27086454 0.89 PDE2A (0.37) BCHEPTPN1CDC25BPDE2AHTR1A
SCHEMBL13667662 0.89 PTPN1 (0.37) BCHEPTPN1CDC25BPDE2AHTR1A
SCHEMBL12243141 0.89 PDE2A (0.37) BCHEPTPN1CDC25BPDE2AHTR1A
SCHEMBL12393373 0.89 PDE2A (0.37) BCHEPTPN1CDC25BPDE2AHTR1A
SCHEMBL31063739 0.89 PDE2A (0.37) BCHEPTPN1CDC25BPDE2AHTR1A
SCHEMBL17106824 0.86 PTPN1 (0.36) BCHEPTPN1CDC25BPDE2AHTR1A
SCHEMBL25259971 0.86 BCHE (0.36) BCHEPTPN1CDC25BPDE2AHTR1A
SCHEMBL19223088 0.83 PTPN1 (0.36) PTPN1CDC25BPDE2AHTR1APTPN2
SCHEMBL25263772 0.83 BCHE (0.36) BCHEPTPN1CDC25BHTR1APTPN2
SCHEMBL25229913 0.83 PTPN1 (0.38) BCHEPTPN1CDC25BHTR1APTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111233869-B Novel compound for preparing Rudexilvir key intermediate and preparation method thereof 杭州新博思生物医药有限公司 2022-09-16 — — CN disclosed
CN-111233869-A Novel compound for preparing Rudexilvir key intermediate and preparation method thereof 杭州新博思生物医药有限公司 2020-06-05 — — CN disclosed
Send feedback